INVOHV: Lower Limb Tissue Oxygenation Using Near-infrared Spectroscopy During Hallux Valgus Operation

Sponsor
Kuopio University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04533035
Collaborator
(none)
30
1
6
5

Study Details

Study Description

Brief Summary

In acute lower limb ischemia the main goal of the treatment is to restore the blood before irreversible damage to the soft tissues of the limb. Delays in identifying acute lower limb ischemia may lead to limb loss or lead to the loss of the patient. Situations in which the patient is unable to express symptoms of the acute lower limb ischemia, such as during general anesthesia, in intensive care, or immediately after vascular surgery, are challenging for medical staff to identify. A reliable, easy-to-use and non-invasive monitoring method is not yet in every day use. The aim of this study is to demonstrate that Near InfraRed Spectroscopy (NIRS) monitoring is such a monitoring method.

Tourniquet induced ischemia is often used in hallux valgus surgery because it offers a bloodless view of the anatomical structures. In our study we will measure the soft tissue perfusion (rSO2) of the lower limbs during the whole operation. The sensors based on near-infrared spectroscopy will be located to the tibial surface and will record the normal state before the start of the tourniquet, during the tourniquet and also in the recovery phase.

The hypothesis is that rSO2 decreases linearly as a function of time from the beginning of the tourniquet induced ischemia and the recovery time depends on the duration of the tourniquet. In our study the patients will be operated under a spinal anesthesia. We also hypothesise that rSO2 increases due to the induction of the spinal anesthesia. Our goal is to define the percentual decline of rSO2 that is significant for lower limb ischemia and also its time response to induction of ischemia.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    30 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Lower Limb Tissue Oxygenation Using Near-infrared Spectroscopy During Hallux Valgus Operation
    Actual Study Start Date :
    Aug 28, 2020
    Actual Primary Completion Date :
    Feb 26, 2021
    Actual Study Completion Date :
    Feb 26, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    Single cohort

    30 patients undergoing hallux valgus surgery

    Outcome Measures

    Primary Outcome Measures

    1. The percentual decrease of the regional oxygen saturation in the lower limb 15 minutes after the tourniquet is applied. [15 minutes from tourniquet application]

      50% decrease from baseline NIRS value in 15 minutes

    Secondary Outcome Measures

    1. The time that the regional oxygen saturation in the lower limb takes to recover after the tourniquet is released. [From the moment tourniquet is released to the point that NIRS value reaches it's baseline or patient is mobilised in the recovery room, whichever came first, assessed up to two hours.]

      The time to NIRS value to reach baseline value after tourniquet is released

    2. The percentual increase of the regional oxygen saturation in the lower limbs due to the induction of a spinal anesthesia. [30 minutes from induction of spinal anesthesia]

      10% increase in NIRS value after 30 minutes after spinal anesthesia induction

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patient understands the meaning of the study and related measures.

    • Patient gives his or her written informed consent.

    • A tourniquet is used.

    • The procedure is performed under spinal anesthesia.

    • Body mass index under 40.

    Exclusion Criteria:
    • Patient belongs to any of the following special groups: disabled people, minor, pregnant or breast feeding women, convicts, forensic psychiatric patients.

    • Previous lower limb vascular surgery.

    • Previous lower limb deep vein thrombosis.

    • Previously performed tibial fasciotomies.

    • Any another reason why the researcher considers that the patient is not suitable for the study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Kuopio University Hospital Kuopio Finland 70100

    Sponsors and Collaborators

    • Kuopio University Hospital

    Investigators

    • Study Director: Kimmo Mäkinen, docent, Kuopio University Hospital
    • Principal Investigator: Anna H Govenius, MD, Kuopio University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Anna Govenius, Specialist in cardiothoracic surgery, MD, Kuopio University Hospital
    ClinicalTrials.gov Identifier:
    NCT04533035
    Other Study ID Numbers:
    • 5101143
    First Posted:
    Aug 31, 2020
    Last Update Posted:
    Mar 2, 2021
    Last Verified:
    Mar 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Anna Govenius, Specialist in cardiothoracic surgery, MD, Kuopio University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 2, 2021